CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to compare the efficacy and safety of albuterol/budesonide to albuterol in changes in airway inflammation, asthma...
Phase 4
Phoenix, Arizona, United States and 18 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Surprise, Arizona, United States and 196 other locations
Primary Objective:* To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a p...
Phase 3
Gilbert, Arizona, United States and 79 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Phoenix, Arizona, United States and 115 other locations
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....
Phase 3
Phoenix, Arizona, United States and 136 other locations
BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...
Phase 2
Chandler, Arizona, United States and 158 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Phoenix, Arizona, United States and 57 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Phoenix, Arizona, United States and 381 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Phoenix, Arizona, United States and 318 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Phoenix, Arizona, United States and 419 other locations
Clinical trials
Research sites
Resources
Legal